Cargando…

Interleukin-6-knockdown of chimeric antigen receptor-modified T cells significantly reduces IL-6 release from monocytes

BACKGROUND: T cells expressing a chimeric antigen receptor (CAR) engineered to target CD19 can treat leukemia effectively but also increase the risk of complications such as cytokine release syndrome (CRS) and CAR T cell related encephalopathy (CRES) driven by interleukin-6 (IL-6). Here, we investig...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kang, Liqing, Tang, Xiaowen, Zhang, Jian, Li, Minghao, Xu, Nan, Qi, Wei, Tan, Jingwen, Lou, Xiaoyan, Yu, Zhou, Sun, Juanjuan, Wang, Zhenkun, Dai, Haiping, Chen, Jia, Lin, Guoqing, Wu, Depei, Yu, Lei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278071/ https://www.ncbi.nlm.nih.gov/pubmed/32523801 http://dx.doi.org/10.1186/s40164-020-00166-2

Ejemplares similares

Characterization of novel dual tandem CD19/BCMA chimeric antigen receptor T cells to potentially treat multiple myeloma
por: Kang, Liqing, et al.
Publicado: (2020)

Preclinical efficacy and safety evaluation of interleukin-6-knockdown CAR-T cells targeting at CD19
por: Wen, Hairuo, et al.
Publicado: (2021)

Interleukin (IL)-6 Inhibits IL-27- and IL-30-Mediated Inflammatory Responses in Human Monocytes
por: Petes, Carlene, et al.
Publicado: (2018)

Special issue on Interleukin-6 (IL-6)
por: Rincon, Mercedes
Publicado: (2012)

Interleukin-1 beta and interleukin-6 release by peripheral blood monocytes in head and neck cancer.
por: Gallo, O., et al.
Publicado: (1993)

Adiponectin-induced secretion of interleukin-6 (IL-6), monocyte chemotactic protein-1 (MCP-1, CCL2) and interleukin-8 (IL-8, CXCL8) is impaired in monocytes from patients with type I diabetes
por: Abke, Sabine, et al.
Publicado: (2006)

Role of interleukin 4 (IL4) and interleukin 6 (IL6) in the pathogenesis and prognosis of childhood primary immune thrombocytopenia
por: Zakaria, Marwa, et al.
Publicado: (2023)

Cathepsin S provokes interleukin-6 (IL-6) trans-signaling through cleavage of the IL-6 receptor in vitro
por: Flynn, Charlotte M., et al.
Publicado: (2020)

Role of interleukin-6 (IL-6) in predicting gestational diabetes mellitus
por: Amirian, Azam, et al.
Publicado: (2020)

Interleukin‐6 signaling requires only few IL‐6 molecules: Relation to physiological concentrations of extracellular IL‐6
por: Hansen, Morten B.
Publicado: (2020)

Endothelin-1 stimulates human monocytes in vitro to release TNF-α , IL-1β and IL-6
por: Helset, E., et al.
Publicado: (1993)

Interleukin-6 serum level and monocyte production in head and neck cancer.
por: Gallo, O., et al.
Publicado: (1992)

The function of the soluble interleukin 6 (IL-6) receptor in vivo: sensitization of human soluble IL-6 receptor transgenic mice towards IL- 6 and prolongation of the plasma half-life of IL-6
Publicado: (1996)

Clinical significance of interleukin (IL)-6 in cancer metastasis to bone: potential of anti-IL-6 therapies
por: Tawara, Ken, et al.
Publicado: (2011)

Interleukin-6 RNA knockdown ameliorates acute lung injury induced by intestinal ischemia reperfusion in rats by upregulating interleukin-10 expression
por: Yuan, Bing, et al.
Publicado: (2017)

Structural Mimicry of Receptor Interaction by Antagonistic Interleukin-6 (IL-6) Antibodies
por: Blanchetot, Christophe, et al.
Publicado: (2016)

Interleukin-6 (IL-6) Receptor Antagonist Protects Against Rheumatoid Arthritis
por: Li, Songsong, et al.
Publicado: (2016)

Tocilizumab does not block interleukin-6 (IL-6) signaling in murine cells
por: Lokau, Juliane, et al.
Publicado: (2020)

Knockdown of IL-1β Improves Hypoxia–ischemia Brain Associated with IL-6 Up-regulation in Cell and Animal Models
por: Liu, Sujuan, et al.
Publicado: (2014)

Ga(III) Nanoparticles Inhibit Growth of both Mycobacterium tuberculosis and HIV and Release of Interleukin-6 (IL-6) and IL-8 in Coinfected Macrophages
por: Choi, Seoung-ryoung, et al.
Publicado: (2017)

Assessment of Interleukins IL-4, IL-6, IL-8, IL-10 in Acute Urticaria
por: Papadopoulos, Jordan, et al.
Publicado: (2014)

Accelerated Nerve Regeneration in Mice by upregulated expression of interleukin (IL) 6 and IL-6 receptor after trauma
Publicado: (1996)

Development of an interleukin (IL) 6 receptor antagonist that inhibits IL-6-dependent growth of human myeloma cells
Publicado: (1994)

Mouse plasmacytoma growth in vivo: enhancement by interleukin 6 (IL-6) and inhibition by antibodies directed against IL-6 or its receptor
Publicado: (1990)

Understanding the Role of Interleukin-6 (IL-6) in the Joint and Beyond: A Comprehensive Review of IL-6 Inhibition for the Management of Rheumatoid Arthritis
por: Favalli, Ennio G.
Publicado: (2020)

Expression of interleukin 6 (IL-6) correlates with oestrogen receptor in human breast carcinoma
por: Fontanini, G, et al.
Publicado: (1999)

Deletion of interleukin-6 in monocytes/macrophages suppresses the initiation of hepatocellular carcinoma in mice
por: Kong, Lingxiang, et al.
Publicado: (2016)

Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes
Publicado: (1991)

Chimeric antigen receptors containing the OX40 signalling domain enhance the persistence of T cells even under repeated stimulation with multiple myeloma target cells
por: Tan, Jingwen, et al.
Publicado: (2022)

Regulation of interleukin 6 receptor expression in human monocytes and monocyte-derived macrophages. Comparison with the expression in human hepatocytes
Publicado: (1989)

IL-6/IFN-γ double knockdown CAR-T cells reduce the release of multiple cytokines from PBMCs in vitro
por: Zhang, Huihui, et al.
Publicado: (2022)

Palmitate and insulin synergistically induce IL-6 expression in human monocytes
por: Bunn, Robert C, et al.
Publicado: (2010)

Interleukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors
Publicado: (1995)

Extramedullary Expansion of Hematopoietic Progenitor Cells in Interleukin (IL)-6–sIL-6R Double Transgenic Mice
por: Peters, Malte, et al.
Publicado: (1997)

Methotrexate induces production of IL-1 and IL-6 in the monocytic cell line U937
por: Olsen, Nancy J, et al.
Publicado: (2014)

Athletic humans and horses: Comparative analysis of interleukin-6 (IL-6) and IL-6 receptor (IL-6R) expression in peripheral blood mononuclear cells in trained and untrained subjects at rest
por: Capomaccio, Stefano, et al.
Publicado: (2011)

Interleukin (IL)-6 Directs the Differentiation of IL-4–producing CD4(+) T Cells
por: Rincón, Mercedes, et al.
Publicado: (1997)

Diesel Exhaust Particles Upregulate Interleukins IL-6 and IL-8 in Nasal Fibroblasts
por: Kim, Jin Ah, et al.
Publicado: (2016)

Case Report: Reversible Neurotoxicity and a Clinical Response Induced by BCMA-Directed Chimeric Antigen Receptor T Cells Against Multiple Myeloma With Central Nervous System Involvement
por: Zhang, Ying, et al.
Publicado: (2021)

The Many Faces of Interleukin-6: The Role of IL-6 in Inflammation, Vasculopathy, and Fibrosis in Systemic Sclerosis
por: Barnes, Theresa C., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_5qde8pd8d314chsna89gfpl6no